FDA.reportPublic FDA data

dextroamphetamine 18 MG in 9 HR Transdermal System

RxCUI
2624712
RxNorm name
dextroamphetamine 18 MG in 9 HR Transdermal System
Display name
dextroamphetamine 18 MG in 9 HR Transdermal System
Full name
dextroamphetamine 18 MG in 9 HR Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0862f02a-72a8-41cc-8845-57cf4974bb6fdextroamphetamine 18 MG in 9 HR Transdermal System [PSN] · 9 HR dextroamphetamine 2 MG/HR Transdermal System [SCD] · dextroamphetamine 18 MG per 9 HR Transdermal System [SY]317These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 197520251223